India racing to outpace any surge in Covid-19 cases via inoculation drive

Second only to the US, India has administered more than 25 million doses, so far

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
The health ministry has said the capacity per day was doubled from 1 million vaccinations on March 4 to 2 million vaccinations on March 8
Ruchika Chitravanshi New Delhi
1 min read Last Updated : Mar 12 2021 | 6:10 AM IST
Over a year into the pandemic and just about two months into the vaccination drive, India is racing to outpace any surge in Covid cases  through the nationwide inoculation drive. Second only to the US, India has administered more than 25 million doses, so far. But for a country the size of India, the pace of vaccination has to pick up significantly to cover a large chunk of population in a short span of time. Over 6.7 million people over 60 and 45 years of age with comorbidities have received their first dose. The target group is of around 270 million. 

The health ministry has said the capacity per day was doubled from 1 million vaccinations on March 4 to 2 million vaccinations on March 8. The daily number had dwindled after that due to fewer sessions in states on some days. Almost 30% of vaccinations are being done in the private sector.



One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineVaccination

Next Story